Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
Voyager Therapeutics (Nasdaq: VYGR), a biotechnology company focused on neurogenetic medicines, has announced its participation in two upcoming investor conferences in March 2025.
The company will attend the TD Cowen 45th Annual Health Care Conference in Boston, with a fireside chat scheduled for March 3, 2025, at 1:50 p.m. ET. Additionally, Voyager will participate in the Stifel 2025 Virtual CNS Forum, featuring a fireside chat on March 19, 2025, at 11:00 a.m. ET.
Webcasts of both presentations will be available through the Investors section of Voyager's website at ir.voyagertherapeutics.com. Interested parties can access replays of the webcasts, which will remain archived on the company's website for a minimum of 30 days after the events.
Voyager Therapeutics (Nasdaq: VYGR), una compagnia biotecnologica focalizzata su medicinali neurogenetici, ha annunciato la sua partecipazione a due conferenze per investitori in programma a marzo 2025.
L'azienda parteciperà alla 45ª Conferenza Annuale sulla Salute di TD Cowen a Boston, con una chiacchierata informale programmata per il 3 marzo 2025, alle 13:50 ET. Inoltre, Voyager parteciperà al Forum Virtuale CNS di Stifel 2025, che includerà una chiacchierata informale il 19 marzo 2025, alle 11:00 ET.
I webcast di entrambe le presentazioni saranno disponibili nella sezione Investitori del sito web di Voyager all'indirizzo ir.voyagertherapeutics.com. Le parti interessate potranno accedere alle registrazioni dei webcast, che rimarranno archiviate sul sito dell'azienda per un minimo di 30 giorni dopo gli eventi.
Voyager Therapeutics (Nasdaq: VYGR), una empresa biotecnológica enfocada en medicamentos neurogenéticos, ha anunciado su participación en dos conferencias de inversores que se llevarán a cabo en marzo de 2025.
La compañía asistirá a la 45ª Conferencia Anual de Salud de TD Cowen en Boston, con un chat junto a la chimenea programado para el 3 de marzo de 2025, a la 1:50 p.m. ET. Además, Voyager participará en el Foro Virtual CNS de Stifel 2025, que contará con un chat junto a la chimenea el 19 de marzo de 2025, a las 11:00 a.m. ET.
Las transmisiones en vivo de ambas presentaciones estarán disponibles en la sección de Inversores del sitio web de Voyager en ir.voyagertherapeutics.com. Las partes interesadas podrán acceder a las repeticiones de las transmisiones, que permanecerán archivadas en el sitio web de la empresa durante un mínimo de 30 días después de los eventos.
보이저 테라퓨틱스 (Nasdaq: VYGR), 신경 유전 의약품에 중점을 둔 생명공학 회사가 2025년 3월에 열리는 두 개의 투자자 회의에 참여할 것이라고 발표했습니다.
회사는 보스턴에서 열리는 TD Cowen 제45회 연례 건강 관리 회의에 참석하며, 2025년 3월 3일 오후 1시 50분 ET에 화상 대화가 예정되어 있습니다. 또한, 보이저는 Stifel 2025 가상 CNS 포럼에도 참여하며, 2025년 3월 19일 오전 11시에 화상 대화가 진행됩니다.
두 발표의 웹캐스트는 보이저 웹사이트의 투자자 섹션(ir.voyagertherapeutics.com)을 통해 제공됩니다. 관심 있는 분들은 이벤트 후 최소 30일 동안 회사 웹사이트에 보관될 웹캐스트의 재생을 이용할 수 있습니다.
Voyager Therapeutics (Nasdaq: VYGR), une entreprise de biotechnologie axée sur les médicaments neurogénétiques, a annoncé sa participation à deux conférences pour investisseurs prévues en mars 2025.
L'entreprise assistera à la 45e Conférence Annuelle sur la Santé de TD Cowen à Boston, avec une discussion informelle prévue pour le 3 mars 2025, à 13h50 ET. De plus, Voyager participera au Forum Virtuel CNS de Stifel 2025, qui comprendra une discussion informelle le 19 mars 2025, à 11h00 ET.
Les webcasts des deux présentations seront disponibles dans la section Investisseurs du site Web de Voyager à l'adresse ir.voyagertherapeutics.com. Les parties intéressées pourront accéder aux rediffusions des webcasts, qui resteront archivées sur le site de l'entreprise pendant au moins 30 jours après les événements.
Voyager Therapeutics (Nasdaq: VYGR), ein Biotechnologieunternehmen, das sich auf neurogenetische Medikamente konzentriert, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im März 2025 angekündigt.
Das Unternehmen wird an der 45. jährlichen Gesundheitskonferenz von TD Cowen in Boston teilnehmen, mit einem Fireside-Chat, der für den 3. März 2025, um 13:50 Uhr ET geplant ist. Darüber hinaus wird Voyager am Stifel 2025 virtuellen CNS-Forum teilnehmen, das einen Fireside-Chat am 19. März 2025, um 11:00 Uhr ET beinhaltet.
Webcasts beider Präsentationen werden im Investorenbereich der Website von Voyager unter ir.voyagertherapeutics.com verfügbar sein. Interessierte können die Aufzeichnungen der Webcasts abrufen, die mindestens 30 Tage nach den Veranstaltungen auf der Website des Unternehmens archiviert bleiben.
- None.
- None.
LEXINGTON, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the Company will participate in multiple upcoming investor conferences:
- TD Cowen 45th Annual Health Care Conference, in Boston, including a fireside chat at 1:50 p.m. ET on March 3, 2025
- Stifel 2025 Virtual CNS Forum, including a fireside chat at 11:00 a.m. ET on March 19, 2025
Webcasts of the presentations will be available and may be accessed from the Investors section of Voyager’s website at ir.voyagertherapeutics.com. A replay of the webcasts will be archived on the Company’s website for at least 30 days.
About Voyager Therapeutics
Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACER™ AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs are wholly owned, and some are advancing with partners including Alexion, AstraZeneca Rare Disease; Novartis Pharma AG; and Neurocrine Biosciences, Inc. For more information, visit www.voyagertherapeutics.com.
Voyager Therapeutics® is a registered trademark, and TRACER™ is a trademark, of Voyager Therapeutics, Inc.
Contacts
Trista Morrison, NACD.DC, tmorrison@vygr.com
Investors: Mike Hencke, mhencke@kendallir.com
Media: Brooke Shenkin, brooke@scientpr.com
FAQ
When is Voyager Therapeutics (VYGR) presenting at the TD Cowen Health Care Conference?
What investor conferences will VYGR attend in March 2025?
How can investors access Voyager Therapeutics' (VYGR) conference presentations?
How long will VYGR's conference webcasts be available for replay?
What time is Voyager Therapeutics presenting at the Stifel 2025 Virtual CNS Forum?
